- Prototype ready
- 3 clinical partners hospitals: 1 clinical study concluded, 1 pending and 1 about to start in November
- CE mark on progress to be received by December (we have a first CE mark for the same technology applied to another target group, so we don;t have particular issues with the medical device certification)
- clear regulatory, clinical roadmap, cybersecurity and privacy, and validated go to market strategy
Problem or Opportunity
Only 16% of asthma patients can manage their disease accurately.
This leads to increase asthma attacks and hospitalization.
2/3 of asthma death coming from respiratory attacks could be preventable with good self-management.
Solution (product or service)
Self-management app for people with asthma, to know the current status of the disease whenever they want, from their phone. It works by collecting sounds of breathing through breathing exercises and analyzing the sound with our machine learning algorithm.
Unlike other solutions that focus either on additional hardware, or only on wellbeing space, VoiceMed solution manages high engagement with personalized breathing programs & feedback, and personalized measurement of the disease directly from the phone, available with 1 click in the pocket.
Business model
B2C targeting asthma patients with freemium model (patients get access to 70% of the app for free) and a monthly subscription fee for premium features on personalization.
In the meantime we are on the process for reimbursement in UK which will take a bit more than 1 year after the product is on the market.
Initial target market UK, second Germany
Incubation/Acceleration programs accomplishment
Fit4start
Open accelerator
EIT med-tech bootcamp
Covid X
